BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32013195)

  • 1. Characterization of Lysine Acetyltransferase Activity of Recombinant Human ARD1/NAA10.
    Vo TTL; Park JH; Lee EJ; Nguyen YTK; Han BW; Nguyen HTT; Mun KC; Ha E; Kwon TK; Kim KW; Jeong CH; Seo JH
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32013195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-terminal Acetyltransferase Naa10/ARD1 Does Not Acetylate Lysine Residues.
    Magin RS; March ZM; Marmorstein R
    J Biol Chem; 2016 Mar; 291(10):5270-7. PubMed ID: 26755727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Versatility of ARD1/NAA10-mediated protein lysine acetylation.
    Vo TTL; Jeong CH; Lee S; Kim KW; Ha E; Seo JH
    Exp Mol Med; 2018 Jul; 50(7):1-13. PubMed ID: 30054464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxylation of the Acetyltransferase NAA10 Trp38 Is Not an Enzyme-Switch in Human Cells.
    Ree R; Krogstad K; McTiernan N; Jakobsson ME; Arnesen T
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of the human ARD1-NATH protein acetyltransferase complex.
    Arnesen T; Anderson D; Baldersheim C; Lanotte M; Varhaug JE; Lillehaug JR
    Biochem J; 2005 Mar; 386(Pt 3):433-43. PubMed ID: 15496142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF-1alpha fragments in vitro.
    Murray-Rust TA; Oldham NJ; Hewitson KS; Schofield CJ
    FEBS Lett; 2006 Apr; 580(8):1911-8. PubMed ID: 16500650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoacetylation regulates differentially the roles of ARD1 variants in tumorigenesis.
    Seo JH; Park JH; Lee EJ; Vo TT; Choi H; Jang JK; Wee HJ; Ahn BJ; Cha JH; Shin MW; Kim KW
    Int J Oncol; 2015 Jan; 46(1):99-106. PubMed ID: 25338643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-α-acetyltransferase 10 (NAA10) in development: the role of NAA10.
    Lee MN; Kweon HY; Oh GT
    Exp Mol Med; 2018 Jul; 50(7):1-11. PubMed ID: 30054454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FIH permits NAA10 to catalyze the oxygen-dependent lysyl-acetylation of HIF-1α.
    Kang J; Chun YS; Huh J; Park JW
    Redox Biol; 2018 Oct; 19():364-374. PubMed ID: 30237125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse roles of arrest defective 1 in cancer development.
    Chaudhary P; Ha E; Vo TTL; Seo JH
    Arch Pharm Res; 2019 Dec; 42(12):1040-1051. PubMed ID: 31813105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biological functions of Naa10 - From amino-terminal acetylation to human disease.
    Dörfel MJ; Lyon GJ
    Gene; 2015 Aug; 567(2):103-31. PubMed ID: 25987439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel NAA10 p.(R83H) variant with impaired acetyltransferase activity identified in two boys with ID and microcephaly.
    Ree R; Geithus AS; Tørring PM; Sørensen KP; Damkjær M; ; Lynch SA; Arnesen T
    BMC Med Genet; 2019 Jun; 20(1):101. PubMed ID: 31174490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metagenomic characterization of lysine acetyltransferases in human cancer and their association with clinicopathologic features.
    Jiang Y; Guo X; Liu L; Rode S; Wang R; Liu H; Yang ZQ
    Cancer Sci; 2020 May; 111(5):1829-1839. PubMed ID: 32162442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different subcellular localizations and functions of human ARD1 variants.
    Seo JH; Park JH; Lee EJ; Kim KW
    Int J Oncol; 2015 Feb; 46(2):701-7. PubMed ID: 25421966
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Kweon HY; Lee MN; Dorfel M; Seo S; Gottlieb L; PaPazyan T; McTiernan N; Ree R; Bolton D; Garcia A; Flory M; Crain J; Sebold A; Lyons S; Ismail A; Marchi E; Sonn SK; Jeong SJ; Jeon S; Ju S; Conway SJ; Kim T; Kim HS; Lee C; Roh TY; Arnesen T; Marmorstein R; Oh GT; Lyon GJ
    Elife; 2021 Aug; 10():. PubMed ID: 34355692
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    McTiernan N; Darbakk C; Ree R; Arnesen T
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-end rule pathway enzyme Naa10 supports epiblast specification in mouse embryonic stem cells by modulating FGF/MAPK.
    Takekoshi D; Tokuzawa Y; Sakanaka M; Kato H
    In Vitro Cell Dev Biol Anim; 2019 May; 55(5):355-367. PubMed ID: 30993557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear translocation of hARD1 contributes to proper cell cycle progression.
    Park JH; Seo JH; Wee HJ; Vo TT; Lee EJ; Choi H; Cha JH; Ahn BJ; Shin MW; Bae SJ; Kim KW
    PLoS One; 2014; 9(8):e105185. PubMed ID: 25133627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARD1/NAA10 acetylation in prostate cancer.
    Kuhns KJ; Zhang G; Wang Z; Liu W
    Exp Mol Med; 2018 Jul; 50(7):1-8. PubMed ID: 30054487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of ARD1 variants in mammalian cells.
    Kim SH; Park JA; Kim JH; Lee JW; Seo JH; Jung BK; Chun KH; Jeong JW; Bae MK; Kim KW
    Biochem Biophys Res Commun; 2006 Feb; 340(2):422-7. PubMed ID: 16376303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.